Janus Henderson Group’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-44,526
| Closed | -$67.5K | – | 2636 |
|
|
2023
Q1 | $67.5K | Buy |
44,526
+26,787
| +151% | +$40.6K | ﹤0.01% | 2644 |
|
|
2022
Q4 | $44.3K | Sell |
17,739
-17,735
| -50% | -$44.3K | ﹤0.01% | 2423 |
|
|
2022
Q3 | $150K | Buy |
35,474
+17,783
| +101% | +$75.2K | ﹤0.01% | 2451 |
|
|
2022
Q2 | $50K | Sell |
17,691
-39
| -0.2% | -$110 | ﹤0.01% | 2554 |
|
|
2022
Q1 | $102K | Buy |
+17,730
| New | +$102K | ﹤0.01% | 2556 |
|
|
2020
Q4 | – | Sell |
-464,301
| Closed | -$6.88M | – | 1400 |
|
|
2020
Q3 | $6.88M | Sell |
464,301
-216,454
| -32% | -$3.21M | ﹤0.01% | 879 |
|
|
2020
Q2 | $10M | Sell |
680,755
-2,489,265
| -79% | -$36.6M | 0.01% | 805 |
|
|
2020
Q1 | $37.2M | Sell |
3,170,020
-1,745,293
| -36% | -$20.5M | 0.03% | 526 |
|
|
2019
Q4 | $116M | Sell |
4,915,313
-214,028
| -4% | -$5.03M | 0.06% | 326 |
|
|
2019
Q3 | $94.9M | Buy |
5,129,341
+19,617
| +0.4% | +$363K | 0.05% | 385 |
|
|
2019
Q2 | $95M | Sell |
5,109,724
-87,951
| -2% | -$1.64M | 0.05% | 389 |
|
|
2019
Q1 | $127M | Sell |
5,197,675
-239,865
| -4% | -$5.86M | 0.07% | 319 |
|
|
2018
Q4 | $141M | Buy |
5,437,540
+10,549
| +0.2% | +$274K | 0.09% | 272 |
|
|
2018
Q3 | $172M | Sell |
5,426,991
-443,819
| -8% | -$14M | 0.09% | 261 |
|
|
2018
Q2 | $228M | Sell |
5,870,810
-2,150,540
| -27% | -$83.5M | 0.13% | 203 |
|
|
2018
Q1 | $221M | Buy |
8,021,350
+959,488
| +14% | +$26.5M | 0.13% | 198 |
|
|
2017
Q4 | $128M | Buy |
7,061,862
+1,294,367
| +22% | +$23.4M | 0.08% | 308 |
|
|
2017
Q3 | $93.1M | Buy |
5,767,495
+126,039
| +2% | +$2.04M | 0.06% | 380 |
|
|
2017
Q2 | $78.1M | Buy |
+5,641,456
| New | +$78.1M | 0.05% | 408 |
|